325 related articles for article (PubMed ID: 28973155)
1. High-throughput screening uncovers miRNAs enhancing glioblastoma cell susceptibility to tyrosine kinase inhibitors.
Cunha PP; Costa PM; Morais CM; Lopes IR; Cardoso AM; Cardoso AL; Mano M; Jurado AS; Pedroso de Lima MC
Hum Mol Genet; 2017 Nov; 26(22):4375-4387. PubMed ID: 28973155
[TBL] [Abstract][Full Text] [Related]
2. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
[TBL] [Abstract][Full Text] [Related]
3. PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA.
Nawaz Z; Patil V; Paul Y; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
Mol Cancer; 2016 Nov; 15(1):74. PubMed ID: 27871300
[TBL] [Abstract][Full Text] [Related]
4. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma.
Costa PM; Cardoso AL; Nóbrega C; Pereira de Almeida LF; Bruce JN; Canoll P; Pedroso de Lima MC
Hum Mol Genet; 2013 Mar; 22(5):904-18. PubMed ID: 23201752
[TBL] [Abstract][Full Text] [Related]
6. miRNA-124-3p/neuropilin-1(NRP-1) axis plays an important role in mediating glioblastoma growth and angiogenesis.
Zhang G; Chen L; Khan AA; Li B; Gu B; Lin F; Su X; Yan J
Int J Cancer; 2018 Aug; 143(3):635-644. PubMed ID: 29457830
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of glioblastoma stem cells promoted by miR-128 or miR-302a overexpression enhances senescence-associated cytotoxicity of axitinib.
Cardoso AM; Morais CM; Pena F; Marante T; Cunha PP; Jurado AS; Pedroso de Lima MC
Hum Mol Genet; 2021 Apr; 30(3-4):160-171. PubMed ID: 33438013
[TBL] [Abstract][Full Text] [Related]
8. Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures.
Yerukala Sathipati S; Huang HL; Ho SY
BMC Genomics; 2016 Dec; 17(Suppl 13):1022. PubMed ID: 28155650
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-21 inhibition enhances in vitro chemosensitivity of temozolomide-resistant glioblastoma cells.
Wong ST; Zhang XQ; Zhuang JT; Chan HL; Li CH; Leung GK
Anticancer Res; 2012 Jul; 32(7):2835-41. PubMed ID: 22753745
[TBL] [Abstract][Full Text] [Related]
10. The role of melatonin in angio-miR-associated inhibition of tumorigenesis and invasion in human glioblastoma tumour spheroids.
Doğanlar O; Doğanlar ZB; Delen E; Doğan A
Tissue Cell; 2021 Dec; 73():101617. PubMed ID: 34418770
[TBL] [Abstract][Full Text] [Related]
11. Targeting strategies on miRNA-21 and PDCD4 for glioblastoma.
Wang G; Wang JJ; Tang HM; To SS
Arch Biochem Biophys; 2015 Aug; 580():64-74. PubMed ID: 26142886
[TBL] [Abstract][Full Text] [Related]
12. MiR-124 inhibits the growth of glioblastoma through the downregulation of SOS1.
Lv Z; Yang L
Mol Med Rep; 2013 Aug; 8(2):345-9. PubMed ID: 23817964
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-210 regulates cell proliferation and apoptosis by targeting regulator of differentiation 1 in glioblastoma cells.
Zhang S; Lai N; Liao K; Sun J; Lin Y
Folia Neuropathol; 2015; 53(3):236-44. PubMed ID: 26443314
[TBL] [Abstract][Full Text] [Related]
14. Modulation of miR-21 signaling by MPS1 in human glioblastoma.
Maachani UB; Tandle A; Shankavaram U; Kramp T; Camphausen K
Oncotarget; 2016 Aug; 7(33):52912-52927. PubMed ID: 25991676
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.
Tian T; Mingyi M; Qiu X; Qiu Y
Oncotarget; 2016 Nov; 7(48):79584-79595. PubMed ID: 27792996
[TBL] [Abstract][Full Text] [Related]
16. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
[TBL] [Abstract][Full Text] [Related]
17. Glucosylceramide synthase silencing combined with the receptor tyrosine kinase inhibitor axitinib as a new multimodal strategy for glioblastoma.
Morais CM; Cunha PP; Melo T; Cardoso AM; Domingues P; Domingues MR; Pedroso de Lima MC; Jurado AS
Hum Mol Genet; 2019 Nov; 28(21):3664-3679. PubMed ID: 31518391
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-129-3p suppresses tumor growth by targeting E2F5 in glioblastoma.
Fang DZ; Wang YP; Liu J; Hui XB; Wang XD; Chen X; Liu D
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1044-1050. PubMed ID: 29509253
[TBL] [Abstract][Full Text] [Related]
19. MiR224-3p inhibits hypoxia-induced autophagy by targeting autophagy-related genes in human glioblastoma cells.
Guo X; Xue H; Guo X; Gao X; Xu S; Yan S; Han X; Li T; Shen J; Li G
Oncotarget; 2015 Dec; 6(39):41620-37. PubMed ID: 26536662
[TBL] [Abstract][Full Text] [Related]
20. Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2 : MiR-152-3p regulate glioma cell apoptosis and invasion.
Sun J; Tian X; Zhang J; Huang Y; Lin X; Chen L; Zhang S
J Exp Clin Cancer Res; 2017 Aug; 36(1):100. PubMed ID: 28764788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
